Canada markets closed

PharmaCielo Ltd. (PCLO.V)

TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
0.6100-0.0100 (-1.61%)
At close: 3:59PM EDT
Currency in CAD

Valuation Measures

Market Cap (intraday) 572.14M
Enterprise Value 363.16M
Trailing P/E N/A
Forward P/E 10.82
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)55.44
Price/Book (mrq)1.62
Enterprise Value/Revenue 348.54
Enterprise Value/EBITDA 6-1.94

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-89.75%
S&P500 52-Week Change 316.25%
52 Week High 35.9500
52 Week Low 30.5000
50-Day Moving Average 30.6558
200-Day Moving Average 31.1605

Share Statistics

Avg Vol (3 month) 3163.42k
Avg Vol (10 day) 3215.53k
Shares Outstanding 5118.27M
Float 93.24M
% Held by Insiders 116.39%
% Held by Institutions 13.35%
Shares Short (Jul. 14, 2020) 4202.08k
Short Ratio (Jul. 14, 2020) 41.62
Short % of Float (Jul. 14, 2020) 4N/A
Short % of Shares Outstanding (Jul. 14, 2020) 40.17%
Shares Short (prior month Jun. 14, 2020) 43.6M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:11
Last Split Date 3Jan. 17, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Mar. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,572.65%

Management Effectiveness

Return on Assets (ttm)-38.23%
Return on Equity (ttm)-67.61%

Income Statement

Revenue (ttm)1.3M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)643.48k
EBITDA -32.56M
Net Income Avi to Common (ttm)-33.25M
Diluted EPS (ttm)-0.3410
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.49M
Total Cash Per Share (mrq)0.06
Total Debt (mrq)1.5M
Total Debt/Equity (mrq)4.01
Current Ratio (mrq)2.59
Book Value Per Share (mrq)0.38

Cash Flow Statement

Operating Cash Flow (ttm)-24.58M
Levered Free Cash Flow (ttm)-21.66M